scPharmaceuticals Statistics
Total Valuation
SCPH has a market cap or net worth of $299.53 million. The enterprise value is $310.88 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPH has 53.68 million shares outstanding. The number of shares has increased by 33.47% in one year.
| Current Share Class | 53.68M |
| Shares Outstanding | 53.68M |
| Shares Change (YoY) | +33.47% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 6.20% |
| Owned by Institutions (%) | 44.44% |
| Float | 32.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.79 |
| Forward PS | 2.94 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.85
| Current Ratio | 3.85 |
| Quick Ratio | 2.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.87 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -57.08% |
| Return on Invested Capital (ROIC) | -101.75% |
| Return on Capital Employed (ROCE) | -111.22% |
| Revenue Per Employee | $304,689 |
| Profits Per Employee | -$559,244 |
| Employee Count | 164 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.20% in the last 52 weeks. The beta is 0.35, so SCPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +9.20% |
| 50-Day Moving Average | 4.91 |
| 200-Day Moving Average | 3.64 |
| Relative Strength Index (RSI) | 63.34 |
| Average Volume (20 Days) | 2,238,754 |
Short Selling Information
The latest short interest is 1.34 million, so 2.50% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 1.01M |
| Short % of Shares Out | 2.50% |
| Short % of Float | 4.07% |
| Short Ratio (days to cover) | 3.65 |
Income Statement
In the last 12 months, SCPH had revenue of $49.97 million and -$91.72 million in losses. Loss per share was -$1.77.
| Revenue | 49.97M |
| Gross Profit | 34.21M |
| Operating Income | -66.54M |
| Pretax Income | -57.71M |
| Net Income | -91.72M |
| EBITDA | -66.52M |
| EBIT | -66.54M |
| Loss Per Share | -$1.77 |
Full Income StatementBalance Sheet
The company has $41.09 million in cash and $52.45 million in debt, giving a net cash position of -$11.36 million or -$0.21 per share.
| Cash & Cash Equivalents | 41.09M |
| Total Debt | 52.45M |
| Net Cash | -11.36M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | -21.32M |
| Book Value Per Share | -0.40 |
| Working Capital | 58.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$65.86 million and capital expenditures -$21,000, giving a free cash flow of -$65.88 million.
| Operating Cash Flow | -65.86M |
| Capital Expenditures | -21,000 |
| Free Cash Flow | -65.88M |
| FCF Per Share | -$1.23 |
Full Cash Flow StatementMargins
Gross margin is 68.46%, with operating and profit margins of -133.16% and -183.55%.
| Gross Margin | 68.46% |
| Operating Margin | -133.16% |
| Pretax Margin | -183.55% |
| Profit Margin | -183.55% |
| EBITDA Margin | -133.13% |
| EBIT Margin | -133.16% |
| FCF Margin | n/a |
Dividends & Yields
SCPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.47% |
| Shareholder Yield | -33.47% |
| Earnings Yield | -30.62% |
| FCF Yield | -21.99% |
Analyst Forecast
The average price target for SCPH is $12.00, which is 115.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 115.05% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 52.69% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCPH has an Altman Z-Score of -7.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.22 |
| Piotroski F-Score | 2 |
